Skip to content

Effect of Yoga Therapy as an Add-on to Medical Care in Improving Health and Well-being in Women with Rheumatoid Arthritis

Impact of Adjuvant Yoga Therapy on Biopsychosocial Health in Women with Rheumatoid Arthritis: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100963
Enrollment
80
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Yoga therapy group: The participants in this experimental group will receive Yoga therapy in addition to standard medical management. The intervention will be delivered through guided s

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed Rheumatoid Arthritis Stable on DMARDs for for more than or equal to three months Willingness to participate and comply with study protocol

Exclusion criteria

Exclusion criteria: Acute RA flare-up or comorbid conditions requiring immediate medical intervention Major psychiatric illness or cognitive impairment interfering with participation Pregnancy or significant physical disability limiting yoga practice Regular yoga practice in the past 6 months, defined as more than 2 hours per week of structured yoga practice Engagement in other structured physical exercise programs (e.g., swimming, aerobics, running, weight training, Pilates, or equivalent) in the past 6 months

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of adjuvant yoga therapy intervention in reducing pain and improving functionality and quality of life in women with Rheumatoid ArthritisTimepoint: 12 weeks

Secondary

MeasureTime frame
To assess improvements in fatigue and energy levelsTimepoint: 12 weeks;To evaluate changes in psychological outcomes, including depression and mental health domainsTimepoint: 12 weeks;To observe changes in inflammatory and biological markers, including CRP (C-reactive protein), ESR (Erythrocyte sedimentation rate), CBC (Complete blood count), IL-6 (Interleukin-6)Timepoint: 12 weeks;To assess changes in functional status and mobilityTimepoint: 12 weeks

Countries

India

Contacts

Public ContactProf Dr Meena Ramanathan

Institute of Salutogenesis and Complementary Medicine (ISCM)

meenayoga@mgmcri.ac.in9790582999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026